Guideline update - transbronchial cryobiopsy in patients with undiagnosed ILD

In today’s episode our Clinical Application Manager Dr. Niklas Froemmel is talking with Dr. Lauren Troy from Royal Prince Alfred Hospital Sydney and Prof. Venerino Poletti from Morgagni Hospital Forli in Italy.
Today’s episode is about the latest guideline update on the role of transbronchial cryobiopsy in patients with idiopathic pulmonary fibrosis. Our experts discuss the data that has paved the way towards this update. They highlight perspectives and trends identified in this new technique, including the FROSTBITE-1 study on the safety of the novel through the sheath cryobiopsy with the 1.1 mm cryoprobe.
More information on: bronchoscopy.erbe-med.com
Important note
The information, recommendations and other details contained in this medium (“information″) reflect our state of knowledge and the state of the art in science and technology at the time the medium was created. The information is of a general nature, non-binding and intended solely for general information purposes; it does not constitute instructions for use. The information and recommendations contained in this medium do not create any legal obligations on the part of Erbe Elektromedizin GmbH and its affiliated companies (“Erbe″) or any other claims against Erbe. The information does not constitute any guarantees or other information on the nature of the product; such information requires an express contractual agreement with Erbe in each individual case. Erbe is not liable for any kind of damage resulting from following the information on this medium, regardless of any legal grounds for liability. Every user of an Erbe product is responsible for testing the respective Erbe product in advance with regard to its properties and its suitability for the intended type of use or purpose. Suitable type of use of the respective Erbe product can be found in the instructions for use for the respective Erbe product. The user is obliged to ascertain whether the instructions for use available to him/her correspond to the current status of the specific Erbe product. Devices may only be used in accordance with the instructions for use. Information on settings, application sites, application duration and use of the respective Erbe product is based on the clinical experience of individual centers, physicians and clinical literature independent of Erbe as well as post market surveillance and empirical evidence. They constitute reference values, or Experienced Starting Settings, which must be checked by the user to ensure that they are suitable for the specifically planned application. Depending on the circumstances of a specific application, it may be necessary to deviate from the information provided. The user is responsible for checking this when using Erbe products. We wish to note that science and technology are subject to constant development as a result of research and clinical experience. Similarly, medicine and clinical application are constantly evolving as a result of research and technological development. This may also make it necessary for the user to deviate from the information provided on this medium. This medium contains information about Erbe products that may not be approved/cleared in certain countries. The user of the respective Erbe product is obliged to inform himself/herself as to whether the Erbe product he/she is using is legally approved/cleared in his/her country and/or to what extent, if any, there are legal requirements for or restrictions on its use.